Board of Dental Examiners


    Click Here to Renew by Paper Forms    


Alaska's Prescription Drug Monitoring Program


What Prescribers and Pharmacists Need to Know about the PDMP


Starting July 17, 2017:

  • Mandatory registration by all pharmacists who dispense a federally controlled substances II, III and IV and DEA registered prescribers licensed in the State of Alaska.
  • Practitioner must review PDMP information before dispensing, prescribing, or administering a federal schedule II or III controlled substance. The exception(s) are:
    • receiving treatment in an inpatient setting;
    • at the scene of an emergency or in an ambulance;
    • in an emergency room;
    • immediately before, during, or within the first 48 hours after surgery or a medical procedure;
    • in a hospice or nursing home that has an in house pharmacy;
    • a nonrefillable prescription of a controlled substance in a quantity intended to last for not more than three days.
  • Collection of all schedule II, III, or IV controlled substances dispensed in the state; schedule V controlled substances are no longer collected.
  • Delegate access is now allowed, but with limitations; a registered pharmacist or prescriber may allow access to the PDMP by an agent or employee, who is licensed or registered under AS 08, by creating a sub-account within the PDMP under their corresponding prescriber or pharmacist account. Sign up instructions for delegates are coming soon.
  • Unsolicited reports may be provided to both prescribers and pharmacists when a patient appears to be receiving multiple Schedule II-IV prescriptions from multiple pharmacies and multiple prescribers; the current threshold is set at 5 prescribers / 5 dispensers in a 3-month period.
  • Reporting frequency of controlled substances dispensed will change to weekly.

PDMP Web Page:     Register   |   Sign In   |   Submit Data   |   Find Information

Joint Committee on Prescriptive Guidelines Report to Alaska State Legislature

Learn more about reducing addiction at:  Opioids.Alaska.Gov


Alaska Prescription Drug monitoring Program


Alaska Prescription Drug monitoring Program



Public Notices

  • Proposed Regulations Changes
  • Notice of Proposed Changes Relating to Administration of Deep Sedation, General Anesthesia, Moderate Sedation, Minimal Sedation, and Local Anesthetic Agents and Nitrous Oxide Sedation in the Regulations of the Board of Dental Examiners

    Written comments deadline: 5:00 p.m. on July 20, 2017


  • Proposed Regulations Changes
  • The DCCED/CBPL proposes to amend the occupational license fees relating to the Board of Dental Examiners, and to establish nitrous oxide permit application fee for dental hygienists.

    Written comments deadline: 5:00 p.m. on July 20, 2017


The Board of Dental Examiners is staffed by the Division of Corporations, Business, and Professional Licensing. The board consists of six dentists, two dental hygienists, and one public member. Board members are appointed by the governor and confirmed by the Legislature.

The board adopts regulations to carry out laws governing the practice of dentistry and dental hygiene in Alaska. It makes final licensing decisions and takes disciplinary actions against people who violate licensing laws. The board meets four times a year and offers a public comment period at each meeting. Meeting agendas and minutes are available from the licensing examiner and will be posted to this website once prepared.


Professions Regulated by the Board

  • Dentists
    • General Dentistry
    • Parenteral Sedation Permit
    • General Anesthetic Permit
  • Dental Hygienists
    • Dental Hygienist
    • Local Anesthetic Permit
    • Restorative Function Endorsement
  • Dental Radiology

National Organizations

National organizations may provide information on the regulation of the practice of dentistry in other states.


Contact Information

Licensing Examiner: Jedediah Smith
Telephone: (907) 465-2542
Fax: (907) 465-2974
E-mail: boardofdentalexaminers@alaska.gov
P.O. Box 110806
Juneau, AK 99811-0806